Gentex Corp (NASDAQ:GNTX) on Friday reported weaker-than-expected third-quarter results and also slightly narrowed its fiscal 2026 guidance.

Gentex reported adjusted earnings of 47 cents per share, missing analysts’ estimate of 50 cents. Revenue decreased 1% year over year to $647.7 million, missing the consensus estimate of $670.5 million.

Gentex narrowed its fiscal 2026 sales guidance to $$2.65 billion from $2.65 billion to $2.75 billion, compared with the analyst consensus estimate of $2.67 billion. The company reduced its gross margin outlook to 34% to 34.5%, down from 34.5% to 35.5%, reflecting incremental commodity cost pressures of $10 million to $15 million.

The company also lowered its capital expenditure forecast to $100 million to $115 million. It also maintained fiscal 2027 sales guidance of $2.8 billion to $2.9 billion, versus the consensus estimate of $2.8 billion.

“Our third quarter results demonstrate the resilience of our business and the continued benefits of our strategy to grow through technology, product mix, and diversification,” said Steve Downing, President and CEO.

Gentex shares fell 1% to trade at $20.45 on Monday.

These analysts made changes to their price targets on Gentex following earnings announcement.

• Baird analyst David Leiker maintained the stock with a Neutral and lowered the price target from $25 to $24.
• B. Riley Securities analyst Josh Nichols maintained the stock with a Buy and lowered the price target from $29 to $25.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.